Literature DB >> 18809279

An unusual case of leiomyosarcoma of the inferior vena cava in a patient with a duplicated inferior vena cava.

Glenn Wei Leong Tan1, Kok Hoong Chia.   

Abstract

Leiomyosarcoma of primary vascular origin is a rare primary soft tissue tumour, which arises mainly from the inferior vena cava (IVC). Clinical symptoms depend upon the size and location of the tumour and presents usually with abdominal pain, palpable mass and weight loss. Complete surgical resection with clear surgical margin plays a central therapeutic role. The effect of chemotherapy and radiation therapy remains to be evaluated. We report a 64 year old Chinese female who presented with abdominal mass and pain associated with weight loss and was subsequently diagnosed with inferior vena cava leiomyosarcoma. She underwent successful surgical resection but unfortunately developed recurrence of tumour 12 month post-operative. She was also found to have a duplicated inferior vena cave which allowed reconstitution of venous return from the lower limbs after surgical resection of the IVC tumour. We discuss the surgical treatment and results of leiomyosarcoma of the IVC.

Entities:  

Mesh:

Year:  2008        PMID: 18809279     DOI: 10.1016/j.avsg.2008.08.014

Source DB:  PubMed          Journal:  Ann Vasc Surg        ISSN: 0890-5096            Impact factor:   1.466


  2 in total

1.  A case of thoracic esophageal cancer with an unusual type of duplicated inferior vena cava.

Authors:  Ryuta Shintakuya; Hidenori Mukaida; Takeshi Mimura; Takuhiro Ikeda; Wataru Takiyama; Masanori Yoshimitsu; Syuji Saeki; Naoki Hirabayashi
Journal:  Gen Thorac Cardiovasc Surg       Date:  2014-01-29

2.  Primary Leiomyosarcoma in the Inferior Vena Cava Extended to the Right Atrium: A Case Report and Review of the Literature.

Authors:  Shuichi Fujita; Hideaki Takahashi; Yumiko Kanzaki; Tomohiro Fujisaka; Yoshihiro Takeda; Hideki Ozawa; Hiroko Kuwabara; Takahiro Katsumata; Nobukazu Ishizaka
Journal:  Case Rep Oncol       Date:  2016-10-12
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.